T1	SNP 24 28	BsmI
T2	Entity 49 67	Vitamin D Receptor
T3	Cancer 77 90	Breast Cancer
T4	Association 0 11	Association
E1	Association:T4 snp_int:T1 bc:T3
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
T5	SNP 339 348	rs1544410
A1	SNP_Class T5 Common_variant
T6	SNP 360 369	rs2228570
A2	SNP_Class T6 Common_variant
T7	SNP 371 375	FokI
T8	SNP 350 354	BsmI
R2	Equiv Arg1:T5 Arg2:T8	
R3	Equiv Arg1:T6 Arg2:T7	
T9	Entity 329 332	VDR
R4	SNP_coupled_gene Arg1:T5 Arg2:T9	
R5	SNP_coupled_gene Arg1:T6 Arg2:T9	
T10	Spec 382 396	inconsistently
T11	Association 397 407	associated
E2	Association:T11 snp_int:T6 snp_int2:T5 bc:T12
R6	Speculation_marker Arg1:E2 Arg2:T10	
T12	Cancer 413 426	breast cancer
T13	Entity 435 456	Caucasian populations
R7	Population_assignment Arg1:T5 Arg2:T13	
R8	Population_assignment Arg1:T6 Arg2:T13	
T14	Entity 112 121	Pakistani
R9	Population_assignment Arg1:T1 Arg2:T14	
T15	Spec 518 526	possible
T16	Association 527 539	contribution
E3	Association:T16 bc:T18 snp_int:T17
R10	Speculation_marker Arg1:E3 Arg2:T15	
T17	SNP 543 553	these SNPs
T18	Cancer 557 570	breast cancer
T19	Entity 579 588	Pakistani
R11	Population_assignment Arg1:T17 Arg2:T19	
T20	SNP 339 348	rs1544410
T21	SNP 360 369	rs2228570
R12	SNP_coupled_gene Arg1:T20 Arg2:T9	
R13	SNP_coupled_gene Arg1:T21 Arg2:T9	
R14	Member Arg1:T17 Arg2:T20	
R15	Member Arg1:T17 Arg2:T21	
A3	SNP_Class T21 Common_variant
A4	SNP_Class T20 Common_variant
T22	SNP 725 729	BsmI
T23	SNP 734 738	FokI
T24	Entity 856 862	female
R16	Population_assignment Arg1:T17 Arg2:T24	
T25	Association 950 961	association
E4	Association:T25 snp_int:T22 snp_int2:T23 bc:T27
T26	Entity 856 862;936 944	female Pakistan
R17	Population_assignment Arg1:T22 Arg2:T26	
R18	Population_assignment Arg1:T23 Arg2:T26	
T27	Cancer 988 1001	breast cancer
T28	Spec 1011 1023	investigated
R19	Speculation_marker Arg1:E4 Arg2:T28	
T29	Entity 1115 1129	BRCA1/2 status
T30	Entity 1134 1148	family history
R20	Risk_Factor Arg1:T23 Arg2:T30	
R21	Risk_Factor Arg1:T22 Arg2:T30	
R23	Risk_Factor Arg1:T22 Arg2:T29	
R22	Risk_Factor Arg1:T23 Arg2:T29	
T31	Entity 1222 1223	b
T32	SNP 1238 1242	BsmI
R24	SNP_allele Arg1:T32 Arg2:T31	
T33	Association 1290 1294	risk
E5	Association:T33 bc:T35 snp_int:T32
T34	Effect_Type 1266 1275	increased
A5	Effect_Type E5 Increase
R25	Effect_type_marker Arg1:E5 Arg2:T34	
T35	Cancer 1276 1289	breast cancer
R26	Population_assignment Arg1:T32 Arg2:T26	
A6	SNP_Class T32 Common_variant
A7	SNP_Class T22 Common_variant
A8	SNP_Class T23 Common_variant
T36	Neg 1418 1421	non
T37	Entity 1410 1417;1422 1430	BRCA1/2 carriers
R27	Negation_marker Arg1:T37 Arg2:T36	
R28	Risk_Factor Arg1:T32 Arg2:T37	
T38	Level 1491 1499	stronger
T39	Association 1290 1294	risk
E6	Association:T39 snp_int:T41 bc:T35
A9	Effect_Type E6 Increase
A10	Level E6 High
R29	Level_marker Arg1:E6 Arg2:T38	
T40	Entity 1524 1579	positive family history of breast and/or ovarian cancer
T41	SNP 1238 1242	BsmI
A11	SNP_Class T41 Common_variant
R30	SNP_allele Arg1:T41 Arg2:T31	
R31	Risk_Factor Arg1:T41 Arg2:T37	
R32	Risk_Factor Arg1:T41 Arg2:T40	
R33	Effect_type_marker Arg1:E6 Arg2:T34	
T42	Neg 1633 1635	No
T43	Association 1636 1647	association
E7	Association:T43 bc:T44 snp_int:T45
R34	Negation_marker Arg1:E7 Arg2:T42	
T44	Cancer 1653 1666	breast cancer
T45	SNP 1693 1697	FokI
R35	Population_assignment Arg1:T45 Arg2:T26	
T46	SNP 1707 1711	BsmI
T47	Entity 1732 1735	VDR
R36	SNP_coupled_gene Arg1:T46 Arg2:T47	
T48	Spec 1741 1747	may be
T49	Association 1791 1795	risk
E8	Association:T49 snp_int:T46 bc:T52
R37	Speculation_marker Arg1:E8 Arg2:T48	
T50	Entity 1799 1814	Pakistani women
R38	Population_assignment Arg1:T46 Arg2:T50	
T51	Effect_Type 1767 1776	increased
R39	Effect_type_marker Arg1:E8 Arg2:T51	
A12	Effect_Type E8 Increase
T52	Cancer 1777 1790	breast cancer
A13	SNP_Class T46 Common_variant
A14	SNP_Class T45 Common_variant
T53	Neg 1815 1823	negative
T54	Entity 1828 1854	BRCA1/2 germline mutations
R40	Negation_marker Arg1:T54 Arg2:T53	
R41	Risk_Factor Arg1:T46 Arg2:T54	
R42	Equiv Arg1:T54 Arg2:T37	
R43	Equiv Arg1:T9 Arg2:T2	
